Skip to content
R03_D01_Precision_Health_GO_3_Jan24_2500X500_022124_SS_KL

Which growth opportunities are contributing to the integration and adoption of Precision Oncology, Precision Cardiometabolic Solutions, and Sustainability in Pharma?

  • In 2020, cancer claimed 10 million lives globally, with 70% of fatalities occurring in low- and middle-income countries.
  • Nearly 537 million people globally have diabetes, reaching 643 million by 2030 and 783 million by 2045.
  • Among the 17 listed Sustainable Development Goals (SDGs), pharmaceutical value chain companies directly experience the effects of 7.

Precision Oncology is undergoing a transformative shift, leveraging artificial intelligence (AI), machine learning (ML), robotics, and big data-driven tools to redefine targeted treatments. Genetic insights are equipping oncologists with personalized diagnostics, revolutionizing patient care. For cardiometabolic diseases, the landscape is shifting towards patient-centric approaches, blending therapies and genetic research for precision health. As the pharmaceutical industry adapts to environmental regulations, sustainability is driving innovation and strategic partnerships for a greener future.

Download Sample

What are some of the Strategic Imperatives shaping the Precision Health & Pharma industry?

Disruptive Technologies in Precision Oncology:

Leading the evolution of cancer care through oncology informatics and AI-driven diagnostics, advancing precision oncology for superior screening, diagnosis, and treatment results.

Transformative Mega Trends in Precision Cardiometabolic Solutions:

Elevating omics-based research to pioneer safe, effective pharmacological, and digital therapies for the treatment and management of cardiometabolic diseases.

Industry Convergence driving sustainability in Pharma:

Integrating ESG strategies focusing on inventory management, sustainable packaging, and circular economy objectives to meet evolving regulatory standards and drive geographic expansion effectively.

Discover the growth opportunities in Precision Oncology, Precision Cardiometabolic Solutions, and Sustainability in Pharmaceuticals Industry by accessing Frost & Sullivan's latest analysis on the subjects.

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

drive-growth-image-scaled-2